Literature DB >> 19463469

Incomplete stent apposition and delayed tissue coverage are more frequent in drug-eluting stents implanted during primary percutaneous coronary intervention for ST-segment elevation myocardial infarction than in drug-eluting stents implanted for stable/unstable angina: insights from optical coherence tomography.

Nieves Gonzalo1, Peter Barlis, Patrick W Serruys, Hector M Garcia-Garcia, Yoshinobu Onuma, Jurgen Ligthart, Evelyn Regar.   

Abstract

OBJECTIVES: The aim of this study was to compare the frequency of incomplete stent apposition (ISA) and struts not covered by tissue at long-term follow-up (as assessed by optical coherence tomography [OCT]) in drug-eluting stents (DES) implanted during primary percutaneous coronary intervention (PCI) for ST-segment elevation myocardial infarction (STEMI) versus DES implanted for unstable and stable angina.
BACKGROUND: Incomplete stent apposition and the absence of strut endothelialization might be linked to stent thrombosis. DES implanted for STEMI might have a higher risk of thrombosis.
METHODS: Consecutive patients in whom OCT was performed at least 6 months after DES implantation were included in the study. Stent struts were classified on the basis of the presence or absence of ISA and tissue coverage.
RESULTS: Forty-seven lesions in 43 patients (1,356 frames, 10,140 struts) were analyzed (49% stable angina, 17% unstable angina, 34% STEMI). Median follow-up time was 9 (range 7 to 72) months. Drug-eluting stents implanted during primary PCI presented ISA more often than DES implanted in stable/unstable angina patients (75% vs. 25.8%, p = 0.001). The frequency of uncovered struts was also higher in the STEMI group (93.8% vs. 67.7%, p = 0.048). On multivariate analysis, DES implantation in STEMI was the only independent predictor of ISA (odds ratio: 9.8, 95% confidence interval: 2.4 to 40.4, p = 0.002) and the presence of uncovered struts at follow-up (odds ratio: 9.5, 95% confidence interval: 1.0 to 90.3, p = 0.049).
CONCLUSIONS: DES implanted for STEMI had a higher frequency of incompletely apposed struts and uncovered struts as assessed by OCT at follow-up. DES implantation during primary PCI in STEMI was an independent predictor of ISA and the presence of uncovered struts at follow-up.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19463469     DOI: 10.1016/j.jcin.2009.01.012

Source DB:  PubMed          Journal:  JACC Cardiovasc Interv        ISSN: 1936-8798            Impact factor:   11.195


  25 in total

1.  Neointimal tissue characteristics following sirolimus-eluting stent implantation: OCT quantitative tissue property analysis.

Authors:  Jingbo Hou; Haibo Jia; Haixia Liu; Zhigang Han; Shuang Yang; Chenyang Xu; Joseph Schmitt; Shaosong Zhang; Bo Yu; Ik-Kyung Jang
Journal:  Int J Cardiovasc Imaging       Date:  2012-03-16       Impact factor: 2.357

2.  Major determinants for the uncovered stent struts on optical coherence tomography after drug-eluting stent implantation.

Authors:  Byeong-Keuk Kim; Jung-Sun Kim; Changmyung Oh; Young-Guk Ko; Donghoon Choi; Yangsoo Jang; Myeong-Ki Hong
Journal:  Int J Cardiovasc Imaging       Date:  2011-05-31       Impact factor: 2.357

Review 3.  Causes, assessment, and treatment of stent thrombosis--intravascular imaging insights.

Authors:  Daniel S Ong; Ik-Kyung Jang
Journal:  Nat Rev Cardiol       Date:  2015-03-17       Impact factor: 32.419

4.  Drug-coated balloon treatment in coronary artery disease: Recommendations from an Asia-Pacific Consensus Group.

Authors:  Ae-Young Her; Eun-Seok Shin; Liew Houng Bang; Amin Ariff Nuruddin; Qiang Tang; I-Chang Hsieh; Jung-Cheng Hsu; Ong Tiong Kiam; ChunGuang Qiu; Jie Qian; Wan Azman Wan Ahmad; Rosli Mohd Ali
Journal:  Cardiol J       Date:  2019-09-30       Impact factor: 2.737

5.  The 5352 A allele of the pro-inflammatory caspase-1 gene predicts late-acquired stent malapposition in STEMI patients treated with sirolimus stents.

Authors:  Sandrin C Bergheanu; Douwe Pons; Bas L van der Hoeven; Su-San Liem; Bob Siegerink; Martin J Schalij; Johanna G van der Bom; J Wouter Jukema
Journal:  Heart Vessels       Date:  2010-10-30       Impact factor: 2.037

6.  Assessment of the healing process after percutaneous implantation of a cardiovascular device: a systematic review.

Authors:  Elodie Perdreau; Zakaria Jalal; Richard D Walton; Jérôme Naulin; Julie Magat; Bruno Quesson; Hubert Cochet; Olivier Bernus; Jean-Benoît Thambo
Journal:  Int J Cardiovasc Imaging       Date:  2019-11-19       Impact factor: 2.357

7.  Optical coherence tomography guided in-stent thrombus removal in patients with acute coronary syndromes.

Authors:  Alessandro Di Giorgio; Davide Capodanno; Vito Ramazzotti; Fabrizio Imola; Maria Teresa Mallus; Filippo Stazi; Giulia Paoletti; Giuseppe Biondi-Zoccai; Corrado Tamburino; Francesco Prati
Journal:  Int J Cardiovasc Imaging       Date:  2013-02-15       Impact factor: 2.357

8.  Serial endovascular assessment of polytetrafluoroethylene-covered stent: Capabilities and limitations of intravascular imaging modalities affected by a temporal factor.

Authors:  Takumi Kimura; Tomonori Itoh; Shoma Sugawara; Tetsuya Fusazaki; Motoyuki Nakamura; Yoshihiro Morino
Journal:  J Cardiol Cases       Date:  2014-12-19

9.  Coronary optical frequency domain imaging (OFDI) for in vivo evaluation of stent healing: comparison with light and electron microscopy.

Authors:  Christian Templin; Martin Meyer; Maja Franziska Müller; Valentin Djonov; Ruslan Hlushchuk; Ivanka Dimova; Stefanie Flueckiger; Peter Kronen; Michele Sidler; Karina Klein; Flora Nicholls; Jelena-Rima Ghadri; Klaus Weber; Dragica Paunovic; Roberto Corti; Simon P Hoerstrup; Thomas F Lüscher; Ulf Landmesser
Journal:  Eur Heart J       Date:  2010-06-05       Impact factor: 29.983

10.  Impact of strut-vessel distance and underlying plaque type on the resolution of acute strut malapposition: serial optimal coherence tomography analysis after everolimus-eluting stent implantation.

Authors:  Takumi Inoue; Toshiro Shinke; Hiromasa Otake; Masayuki Nakagawa; Hirotoshi Hariki; Tsuyoshi Osue; Masamichi Iwasaki; Yu Taniguchi; Ryo Nishio; Noritoshi Hiranuma; Akihide Konishi; Hiroto Kinutani; Masaru Kuroda; Ken-ichi Hirata
Journal:  Int J Cardiovasc Imaging       Date:  2014-04-19       Impact factor: 2.357

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.